If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
<br /> Pharmafocus<br /> April 2011<br /> Vol 13 Issue 4<br /> <br /> <br /> Takeover talk China chops<br /> drugs prices<br /> <br /> Budget boost<br /> <br /> <br /> Novartis may bid for<br /> Roche again following<br /> boardroom changes (p4)<br /> <br /> Chinese government<br /> orders medicines<br /> price cuts (p8)<br /> <br /> Chancellor's tax breaks<br /> aim to foster life sciences<br /> growth (p10)<br /> <br /> <br /> <br /> <br /> <br /> <br /> VBP: a fait accompli or room for manoeuvre?<br /> <br /> Confusion and complexity about future of pricing plans mirror NHS reform row<br /> <br /> <br />
Pharmafocus
Pharmafocus
Pharmafocus April 2011R&D NewsAstraZeneca
Pharmafocus April 2011R&D NewsAstraZeneca
Pharmafocus April 2011PharmafocusApril 2011
Pharmafocus April 2011PharmafocusApril 2011
Pharmafocus April 2011Roche changes ra
Pharmafocus April 2011Roche changes ra
Pharmafocus April 2011MS drug Gilenya set for
Pharmafocus April 2011MS drug Gilenya set for
Pharmafocus April 2011Finances bigger priorit
Pharmafocus April 2011Finances bigger priorit
Pharmafocus April 2011Novartis offers reassur
Pharmafocus April 2011Novartis offers reassur
Pharmafocus April 2011Japan's pharma industry
Pharmafocus April 2011Japan's pharma industry
v e●loidggntiainl●n
v e●loidggntiainl●n
Pharmafocus April 2011Osborne gives life scie
Pharmafocus April 2011Osborne gives life scie
Pharmafocus April 2011Government inj
Pharmafocus April 2011Government inj
Pharmafocus April 2011Sanofi picks two agenci
Pharmafocus April 2011Sanofi picks two agenci
Pharmafocus April 2011Novo's diabetes drug V
Pharmafocus April 2011Novo's diabetes drug V
Pharmafocus April 2011CommentComms changesH
Pharmafocus April 2011CommentComms changesH
Pharmafocus April 2011NHS trusts shoul
Pharmafocus April 2011NHS trusts shoul
Pharmafocus April 2011Healthcare comms is cha
Pharmafocus April 2011Healthcare comms is cha
Pharmafocus April 2011Social media spr
Pharmafocus April 2011Social media spr
Pharmafocus April 2011Integrate: marketing and
Pharmafocus April 2011Integrate: marketing and
Pharmafocus April 2011ing group. And
Pharmafocus April 2011ing group. And
Pharmafocus April 2011CME Spotlight Eugene Po
Pharmafocus April 2011CME Spotlight Eugene Po
Pharmafocus April 2011Evil big pharma: myth o
Pharmafocus April 2011Evil big pharma: myth o
Pharmafocus April 2011Talking PointThis mont
Pharmafocus April 2011Talking PointThis mont
Pharmafocus April 2011What can crea
Pharmafocus April 2011What can crea
Pharmafocus April 2011InPharmJobsThe latest on
Pharmafocus April 2011InPharmJobsThe latest on
Working LifeWolfgang Wein, head of oncolo
Working LifeWolfgang Wein, head of oncolo
Pharmafocus April 2011Manufacturing and CRO ro
Pharmafocus April 2011Manufacturing and CRO ro
Pharmafocus April 2011as cancer treatmen
Pharmafocus April 2011as cancer treatmen
Pharmafocus April 2011Talking PointDue di
Pharmafocus April 2011Talking PointDue di
The all newInPharm.comJobs boardRegister at
The all newInPharm.comJobs boardRegister at
Pharmafocus April 2011AppointmentsEuropean
Pharmafocus April 2011AppointmentsEuropean
Pharmafocus April 2011 Jim McDer
Pharmafocus April 2011 Jim McDer
Pharmafocus April 2011Publicis buys Indian he
Pharmafocus April 2011Publicis buys Indian he